MED
Medifast Q3 2026 Revenue Down 19.4% Despite Strong Coach Adoption
Medifast reported Q3 revenue of $72.0 million, down 19.4% due to fewer active coaches, though the company anticipates profitability in Q4.
MED news
Latest 4 stories · newest Oct 26, 2026
MED
Medifast Launches Trilivy Metabolic Health System to Expand Beyond Weight Loss
Medifast announced the launch of the Trilivy system and new product formulations utilizing MetaVantage Technology. This strategic pivot to metabolic health addresses industry trends, potentially expanding the company's market relevance.
MED
Medifast executive Jason Groves separated from company with one-month severance package.
Jason Groves voluntarily resigned from Medifast effective May 29, 2026, receiving $35,648.42 in severance pay. The separation represents a routine executive departure with standard severance terms and benefits termination.
MED
Medifast Amends and Restates 2012 Share Incentive Plan
Medifast filed an amended and restated 2012 Share Incentive Plan designed to attract and retain executive talent through equity awards. The plan links compensation to company performance metrics and aligns employee interests with shareholder value creation.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same MED feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/MED/newsSTART FREE